Doximity, Inc. (DOCS) Tops Q2 EPS by 5c, Beats on Revenue; Offers FY24 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Doximity Announces Fiscal 2024 Second Quarter Financial Results
November 9, 2023 4:01 PM EST
Total revenues of $113.6 million, up 11% year-over-year
Net income margin of 27% and adjusted EBITDA margin of 48%
Net income growth of 16% and adjusted EBITDA growth of 18% year-over-year
SAN FRANCISCO--(BUSINESS WIRE)-- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2024 second quarter ended September 30, 2023.
Were proud to make medicine mobile, with another quarter of record engagement across our entire platform, said Jeff Tangney, co-founder and CEO of Doximity. Over 550,000 unique providers used our generative AI,... More
